JP2001213757A - Melanin production inhibitor and beautifying cosmetic - Google Patents
Melanin production inhibitor and beautifying cosmeticInfo
- Publication number
- JP2001213757A JP2001213757A JP2000057856A JP2000057856A JP2001213757A JP 2001213757 A JP2001213757 A JP 2001213757A JP 2000057856 A JP2000057856 A JP 2000057856A JP 2000057856 A JP2000057856 A JP 2000057856A JP 2001213757 A JP2001213757 A JP 2001213757A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- melanin production
- castor
- production inhibitor
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規なメラニン産
生抑制剤および美白作用を有する化粧料に関するもので
ある。TECHNICAL FIELD The present invention relates to a novel melanin production inhibitor and a cosmetic having a whitening effect.
【0002】[0002]
【従来の技術】アミノ酸の一種であるチロシンは、チロ
シナーゼの作用により黒褐色ないし赤褐色の色素・メラ
ニンを生じ、皮膚にシミやソバカスを発生させたりする
原因となる。そこで、チロシナーゼの作用を阻害するな
ど何らかの機構によりメラニンの産生を抑制する作用を
有する物質を用いてメラニンの産生を防止しようとする
試みがなされ、その結果、種々のメラニン産生抑制物質
が見いだされて化粧品や食品の添加成分として提案さ
れ、使われている。その代表的なものは、アスコルビン
酸、硫黄類、ハイドロキノン、コウジ酸、および天然の
植物抽出物である。2. Description of the Related Art Tyrosine, which is a kind of amino acid, produces a dark brown or reddish brown pigment or melanin by the action of tyrosinase, which may cause spots or freckles on the skin. Therefore, attempts have been made to prevent melanin production by using a substance having an action of suppressing melanin production by some mechanism such as inhibiting the action of tyrosinase, and as a result, various melanin production inhibitors have been found. It has been proposed and used as an additive in cosmetics and foods. Representatives are ascorbic acid, sulfur, hydroquinone, kojic acid, and natural plant extracts.
【0003】しかしながら、アスコルビン酸は水分が存
在する場合、安定性の点で問題があり、硫黄類はその特
異臭が欠点となる。ハイドロキノンは効果は顕著である
が毒性が強い。コウジ酸や植物抽出物は、安全性は高い
がチロシナーゼ阻害作用やメラニン産生抑制作用が弱
く、また、植物抽出物には臭い、色等の点で問題のある
ものが多い。[0003] However, ascorbic acid has a problem in terms of stability when water is present, and sulfur has a drawback due to its peculiar odor. Hydroquinone is remarkably effective but highly toxic. Kojic acid and plant extracts are high in safety but weak in tyrosinase inhibitory action and melanin production inhibitory action, and many plant extracts have problems in terms of smell, color, and the like.
【0004】後述する本発明でメラニン産生抑制物質抽
出原料としたトウゴマの根部(漢方名でヒマ根と呼ばれ
ている)については、trans−2−デセン−4,
6,8−トリイン酸メチルエステル、1−トリデセン−
3,5,7,9,11−ペンチイン、β−シトステロー
ル等の生理活性物質を含有することが知られており、破
傷風、テンカン、リュウマチによる疼痛の治療等に利用
されているが、いずれも、メラニン産生の抑制とは無関
係である。[0004] The castor root (referred to as castor root in Chinese medicine) used as a raw material for extracting a melanin production inhibitor in the present invention described below is trans-2-decene-4,
6,8-triic acid methyl ester, 1-tridecene-
It is known that it contains a physiologically active substance such as 3,5,7,9,11-pentiin and β-sitosterol, and is used for treatment of pain due to tetanus, tencan, rheumatism and the like. It has nothing to do with suppression of melanin production.
【0005】[0005]
【発明が解決しようとする課題】本発明の目的は、天然
物由来のメラニン産生抑制物質を見いだし、安全性が高
く化粧料や食品に安心して使用できるメラニン産生抑制
剤として提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to find a melanin production inhibitor derived from a natural product, and to provide a melanin production inhibitor having high safety and which can be used in cosmetics and foods with a sense of security.
【0006】本発明の他の目的は、安全性の高い天然物
由来のメラニン産生抑制物質により美白作用を付与され
た化粧料を提供することにある。[0006] Another object of the present invention is to provide a cosmetic product having a whitening effect provided by a highly safe natural substance-derived melanin production inhibitor.
【0007】[0007]
【課題を解決するための手段】本発明は、トウダイグサ
科の植物・トウゴマ(Ricinus communi
s L.)の根部に含まれていて水、脂肪族アルコー
ル、1,3−ブチレングリコール、またはこれらの混合
物によって抽出されるメラニン産生抑制物質を有効成分
として含有することを特徴とするメラニン産生抑制剤お
よび美白用化粧料を提供するものである。DISCLOSURE OF THE INVENTION The present invention relates to a plant of the family Euphorbiaceae, Ricinus communi.
s L. A) a melanin production inhibitor and a whitening agent, characterized by containing as an active ingredient a melanin production inhibitor which is contained in the root of water, an aliphatic alcohol, 1,3-butylene glycol or a mixture thereof. To provide cosmetics.
【0008】[0008]
【発明の実施の形態】トウゴマはその種子から脂肪油を
採取するためにインド等で栽培されているので、種子採
取後の、通常は廃棄される部分をメラニン産生抑制物質
の抽出原料として利用することができる。DESCRIPTION OF THE PREFERRED EMBODIMENTS Castor is cultivated in India or the like in order to collect fatty oil from its seeds. Therefore, the normally discarded portion after seed collection is used as a raw material for extracting a melanin production inhibitor. be able to.
【0009】トウゴマの根部が特異的に含有するメラニ
ン産生抑制物質の詳細は不明であるが、細切りまたは粉
砕したトウゴマ根部を水、低級脂肪族アルコール(例え
ばメタノール、エタノール)、1,3−ブチレングリコ
ール、またはこれらの混合物を用いて抽出処理すると容
易に溶出して来る。好ましい抽出溶媒は、上記親水性有
機溶媒またはこれと水との混合液である。抽出条件およ
び抽出に用いる装置は特に限定されるものではないが、
好適には、重量比で5〜15倍量の前記抽出溶媒にトウ
ゴマ根部(生のものでも乾燥したものでも差し支えな
い)を浸漬し、常温ないし100℃程度の加熱下にゆる
やかに撹拌しながら可溶性成分を溶出させる。濾過また
は遠心分離して得られる抽出液は、適宜濃縮、乾燥す
る。得られた抽出物はそのままメラニン産生抑制剤とし
て利用してもよいが、必要ならば、メラニン産生抑制作
用の減退を招かない範囲で活性炭処理、吸着樹脂処理、
イオン交換樹脂処理等による精製を施し、さらには任意
の助剤、溶剤等と混合してから製剤化してもよい。The details of the melanin production inhibitor specifically contained in the castor root are unknown, but the cut or ground castor root is composed of water, lower aliphatic alcohols (eg, methanol, ethanol), 1,3-butylene glycol. , Or when they are extracted with a mixture thereof, they are easily eluted. A preferred extraction solvent is the above-mentioned hydrophilic organic solvent or a mixture thereof with water. Although the extraction conditions and the apparatus used for the extraction are not particularly limited,
Preferably, the castor root (whether raw or dried) is immersed in 5 to 15 times by weight of the above-mentioned extraction solvent, and soluble while stirring gently at room temperature to about 100 ° C. Elute the components. The extract obtained by filtration or centrifugation is appropriately concentrated and dried. The resulting extract may be used as it is as a melanin production inhibitor, but if necessary, activated carbon treatment, adsorption resin treatment, as long as the melanin production inhibitory action is not reduced.
The preparation may be purified by ion exchange resin treatment or the like, and further mixed with an optional auxiliary agent, solvent, or the like, and then formulated.
【0010】メラニン産生抑制作用を有するトウゴマ根
部抽出物を化粧料に配合して美白作用のある化粧料とす
る場合の該抽出物の好適配合率は、用いるトウゴマ抽出
物の活性の強さや化粧料の種類によっても異なるが、お
おむね0.0001〜1.0重量%である。[0010] When a castor root extract having a melanin production inhibitory action is blended into a cosmetic to form a cosmetic having a whitening effect, the preferred blending ratio of the extract is determined by the strength of the castor extract used and the activity of the cosmetic. Although it varies depending on the type, the content is approximately 0.0001 to 1.0% by weight.
【0011】トウゴマ根部抽出物を配合することによっ
て他の化粧料構成成分の選択が制限されることはなく、
たとえばアボガド油、コメヌカ油、米胚芽油、ラノリ
ン、スクワラン、ミツロウ等の油性成分;グリセリン、
1,3−ブチレングリコール、コラーゲン、ヒアルロン
酸およびその塩、コンドロイチン酸およびその塩、キチ
ン、キトサン等の保湿剤;グリセロリン脂質、スフィン
ゴリン脂質、グリセロ糖脂質、スフィンゴ糖脂質等の複
合脂質;スーパーオキサイドディスムターゼ、カタラー
ゼ、β−カロチン、イチョウ葉抽出物、ビタミンCおよ
びその誘導体、ビタミンEおよびその誘導体、オウゴン
抽出物、クジン抽出物等の活性酸素消去作用物質;グア
イアズレン、カマアズレンおよびその誘導体、グリチル
リチン酸およびその塩、グリチルレチン酸およびその塩
もしくは誘導体、酸化亜鉛等の抗炎症作用物質;アルニ
カ抽出物、インチンコウ抽出物、オウゴン抽出物、オウ
バク抽出物、オウレン抽出物、カミツレ抽出物、カンゾ
ウ根水抽出物、サンシシ抽出物、シコン抽出物、シャク
ヤク抽出物、ボタンピ抽出物、ジュウヤク抽出物、シラ
カバ抽出物、西洋トチノキ種子抽出物、トウキンセンカ
抽出物、ボタンピ抽出物、ムクロジ抽出物、シナノキ抽
出物、ローズマリー抽出物、セイヨウノコギリ草抽出
物、ヨモギ抽出物、岩白菜抽出物、ヨクイニン抽出物、
アロエ抽出物、ビワ抽出物、モモ抽出物、センキュウ抽
出物、セージ抽出物、トウキ抽出物、ヘチマ抽出物、セ
イヨウボダイジュ抽出物、オタネニンジン抽出物、トウ
ガラシ抽出物、甜茶抽出物、茶抽出物、オトギリソウ抽
出物、マロニエ抽出物、プルーン抽出物、コラーゲン、
加水分解コンキオリン、エラスチン、ビトロネクチン、
フィブロネクチン、プラセンターエキス、ビフィズス菌
培養物、乳酸菌培養物、レイシ菌糸体抽出物、ブクリョ
ウ抽出物、褐藻抽出物、紅藻抽出物、緑藻抽出物等の、
皮膚に対して何らかの好ましい作用を示すことが期待さ
れる植物抽出物、動物性抽出物、微生物由来成分または
藻類抽出物;その他各種ビタミン類、増粘剤、防腐剤、
紫外線吸収剤、香料、酸化防止剤等を、任意に選択して
構成成分とすることができる。[0011] By blending the castor root extract, the selection of other cosmetic components is not restricted,
Oily components such as avocado oil, rice bran oil, rice germ oil, lanolin, squalane, beeswax; glycerin;
Humectants such as 1,3-butylene glycol, collagen, hyaluronic acid and its salts, chondroitic acid and its salts, chitin and chitosan; complex lipids such as glycerophospholipid, sphingolipid, glyceroglycolipid, and glycosphingolipid; superoxide Active oxygen-scavenging substances such as dismutase, catalase, β-carotene, ginkgo biloba extract, vitamin C and its derivatives, vitamin E and its derivatives, gougon extract and kujin extract; guaiazulene, kama azulene and its derivatives, glycyrrhizic acid and Its salts, glycyrrhetinic acid and its salts or derivatives, anti-inflammatory substances such as zinc oxide; arnica extract, cinnamon extract, gibbon extract, oak extract, spinach extract, chamomile extract, licorice root extract, Sa Shish extract, siconium extract, peonies extract, peanut extract, peanut extract, birch extract, western horse chestnut seed extract, calendula extract, peanut extract, sapling extract, linden extract, rosemary extract Stuff, Sawtooth grass extract, Artemisia extract, Iwan Chinese cabbage extract, Yokuinin extract,
Aloe extract, loquat extract, peach extract, senkyu extract, sage extract, touki extract, loofah extract, eucalypt extract, panax ginseng extract, capsicum extract, bean tea extract, tea extract, hypericum Extract, horse chestnut extract, prune extract, collagen,
Hydrolyzed conchiolin, elastin, vitronectin,
Fibronectin, placenta extract, bifidobacterium culture, lactic acid bacteria culture, litchi mycelium extract, kuryo extract, brown algae extract, red algae extract, green algae extract, etc.
Plant extracts, animal extracts, microbial components or algal extracts that are expected to show some favorable effects on the skin; other various vitamins, thickeners, preservatives,
An ultraviolet absorber, a fragrance, an antioxidant, and the like can be arbitrarily selected as constituent components.
【0012】本発明による美白用化粧料の代表的な形態
としては軟こう、クリーム、乳液、ローション、パック
等があるが、これらに限定されるわけではない。Representative forms of the whitening cosmetic composition according to the present invention include, but are not limited to, ointments, creams, emulsions, lotions, packs and the like.
【0013】[0013]
【実施例】以下、実施例を示して本発明を説明する。 製造実施例1 乾燥したトウゴマの根部粗砕物50gに80%エタノー
ル水溶液500mlを加え、還流抽出器で3時間加熱還
流抽出処理を行なった。得られた抽出液を濾過したのち
減圧下に濃縮し、さらに凍結乾燥して、粉末状抽出物
2.1gを得た。The present invention will be described below with reference to examples. Production Example 1 500 g of an 80% aqueous ethanol solution was added to 50 g of the dried crushed castor root, and the mixture was subjected to a reflux extraction treatment with a reflux extractor for 3 hours. The obtained extract was filtered, concentrated under reduced pressure, and freeze-dried to obtain 2.1 g of a powdery extract.
【0014】製造実施例2 乾燥したトウゴマの根部粗砕物50gに水500mlを
加え、還流抽出器で3時間加熱還流抽出処理を行なっ
た。得られた抽出液を濾過したのち減圧下に濃縮し、さ
らに凍結乾燥して、粉末状抽出物5.9gを得た。Production Example 2 500 g of water was added to 50 g of the dried crushed castor root, and the mixture was subjected to reflux extraction for 3 hours with a reflux extractor. The obtained extract was filtered, concentrated under reduced pressure, and freeze-dried to obtain 5.9 g of a powdery extract.
【0015】製造実施例3 乾燥したトウゴマの根部粗砕物50gにエタノール50
0mlを加え、還流抽出器で3時間加熱還流抽出処理を
行なった。得られた抽出液を濾過したのち減圧下に濃縮
し、さらに凍結乾燥して、粉末状抽出物1.4gを得
た。Production Example 3 50 g of dried sesame seeds were ground with 50 g of ethanol.
0 ml was added, and the mixture was subjected to a reflux extraction treatment with a reflux extractor for 3 hours. The obtained extract was filtered, concentrated under reduced pressure, and freeze-dried to obtain 1.4 g of a powdery extract.
【0016】製造実施例4 乾燥したトウゴマの根部粗砕物50gに1,3−ブチレ
ングリコール500mlを加え、95℃で3時間抽出処
理を行なった。得られた抽出液を濾過したのち5℃に5
日間静置し、生じたオリや沈殿物をケイソウ土を用いて
濾過し、澄明な抽出液(固形分濃度0.13%)430
mlを得た。Production Example 4 500 g of 1,3-butylene glycol was added to 50 g of the dried crushed castor root, and extracted at 95 ° C. for 3 hours. The obtained extract is filtered and then cooled to 5 ° C.
The mixture was allowed to stand for a day, and the formed deposits and precipitates were filtered using diatomaceous earth to obtain a clear extract (solid content concentration: 0.13%) 430
ml were obtained.
【0017】製造実施例5 乾燥したトウゴマの根部粗砕物50gに50%1,3−
ブチレングリコール水溶液500mlを加え、95℃で
3時間、抽出処理を行なった。得られた抽出液を濾過し
たのち5℃に5日間静置し、生じたオリや沈殿物をケイ
ソウ土を用いて濾過し、澄明な抽出液(固形分濃度0.
50%)440mlを得た。Production Example 5 50 g of a 50% 1,3-
500 ml of a butylene glycol aqueous solution was added, and extraction was performed at 95 ° C. for 3 hours. After filtering the obtained extract, it was allowed to stand at 5 ° C. for 5 days, and the formed deposits and precipitates were filtered using diatomaceous earth to obtain a clear extract (solid content of 0. 0%).
440 ml of (50%) were obtained.
【0018】試験例1 上記各例で得られた抽出物について、B−16メラノー
マ細胞を用いるメラニン産生抑制作用の試験を行なっ
た。試験法は下記のとおりである。なお、製造実施例
4,5により得られた抽出液については少量を減圧濃縮
・凍結乾燥して乾燥粉末を得、それを試験に供した。Test Example 1 The extract obtained in each of the above examples was tested for its melanin production inhibitory effect using B-16 melanoma cells. The test method is as follows. A small amount of the extract obtained in Production Examples 4 and 5 was concentrated under reduced pressure and freeze-dried to obtain a dry powder, which was subjected to a test.
【0019】メラニン産生抑制試験:培地(10%FB
S−DURBECCO培地;以下同じ)5mlを入れた
25mlのフラスコにB−16メラノーマ細胞1×10
6個を播種し、CO2濃度を5%に調整した37℃のイ
ンキュベーターで5日間前培養する。次いでトリプシン
処理し、遠心分離して細胞を集める。得られた細胞4×
106個を培地5mlを入れた直径60mmのシャーレ
に播種し、24時間培養後、所定の濃度に試料を溶解し
た1mMテオフィリン添加培地で3日間培養する。別
に、試料無添加の培地を用いた培養も行い、以下同様に
操作する。培養後、トリプシン処理しさらに遠心分離し
て細胞を集め、培地2mlを加えて細胞浮遊液を得る。
得られた細胞浮遊液中の細胞数を血球計算板を用いて測
定し、試料無添加時の細胞数を基準として試料添加時の
細胞生存率を算出する。また、細胞数を測定した細胞浮
遊液より5×106個の細胞を採取し、10%DMSO
−1N水酸化ナトリウム溶液3mlを加えて超音波処理
および遠心分離を行ない、上清について475nmにお
ける吸光度を測定し、下記の計算式によりメラニン産生
抑制率を算出する。Melanin production inhibition test: Medium (10% FB)
S-DURBECCO medium; the same applies hereinafter) 1 × 10 B-16 melanoma cells in a 25 ml flask containing 5 ml
Six seeds are inoculated and pre-cultured for 5 days in a 37 ° C. incubator adjusted to a CO 2 concentration of 5%. The cells are then trypsinized and centrifuged to collect the cells. Obtained cells 4x
10 6 cells are inoculated in a Petri dish with a diameter of 60 mm containing 5 ml of medium, cultured for 24 hours, and then cultured for 3 days in a 1 mM theophylline-added medium in which a sample is dissolved to a predetermined concentration. Separately, cultivation is performed using a sample-free medium, and the same operation is performed thereafter. After the culture, the cells are collected by trypsinization and centrifugation, and 2 ml of a medium is added to obtain a cell suspension.
The number of cells in the obtained cell suspension is measured using a hemocytometer, and the cell viability when a sample is added is calculated based on the number of cells when no sample is added. In addition, 5 × 10 6 cells were collected from the cell suspension in which the number of cells was measured, and 10% DMSO was collected.
Ultrasonic treatment and centrifugation are performed by adding 3 ml of a -1N sodium hydroxide solution, the absorbance of the supernatant at 475 nm is measured, and the melanin production inhibition rate is calculated by the following formula.
【0020】 抑制率(%)=[(A−B)/A]×100 但しAは試料無添加培養区の吸光度、Bは試料添加培養
区の吸光度である。試料濃度を段階的に変更して上記試
験を行い、メラニン産生が50%抑制される試料濃度を
内挿法により求める。試験結果は表1のとおりであっ
た。Inhibition rate (%) = [(AB) / A] × 100, where A is the absorbance of the sample-free culture and B is the absorbance of the sample-added culture. The above test is performed by changing the sample concentration stepwise, and the sample concentration at which melanin production is suppressed by 50% is determined by interpolation. The test results were as shown in Table 1.
【0021】[0021]
【表1】 [Table 1]
【0022】実施例1 製造実施例1で得られたトウゴマ抽出物を配合して下記
組成の乳液を乳液製造の常法により製造した。 トウゴマ抽出物(製造実施例1) 0.05g セチルアルコール 0.5g ミツロウ 2g POE(10)モノオレイン酸ソルビタン 1g グリセリンモノステアリン酸エステル 1g ヒアルロン酸ナトリウム 0.1g プロピレングリコール 5g エタノール 3g エチルパラベン 0.3g 香料 0.03g 精製水 残部(全量を100mlとする)Example 1 The castor extract obtained in Production Example 1 was blended to produce an emulsion having the following composition by a conventional method for producing an emulsion. Castor extract (Preparation Example 1) 0.05 g Cetyl alcohol 0.5 g Beeswax 2 g POE (10) sorbitan monooleate 1 g Glycerin monostearate 1 g Sodium hyaluronate 0.1 g Propylene glycol 5 g Ethanol 3 g Ethyl paraben 0.3 g Perfume 0.03 g Purified water Remainder (total amount is 100 ml)
【0023】得られた乳液、および、トウゴマ抽出物を
配合しないほかは上記と同様にして製造した比較例乳液
について、下記の塗布試験を行なった。 塗布試験:肌にシミがあり且つ潤いが足りない25〜4
9歳の女性被験者20名を選抜して二分し、一方のグル
ープには実施例乳液を、他方のグループには比較例乳液
を、それぞれ1日2回、朝夕、顔面に塗布させた。3カ
月間経過後、使用結果について感想を述べさせた。その
結果を表2,3に示す。The following coating test was carried out on the obtained emulsion and the comparative emulsion prepared in the same manner as described above except that the castor extract was not blended. Application test: 25 to 4 with skin spots and insufficient moisture
Twenty 9-year-old female subjects were selected and bisected, and the emulsion of the example was applied to one group and the emulsion of the comparative example was applied to the other group twice a day in the morning and evening and on the face. After a lapse of three months, they were asked to comment on the results of use. Tables 2 and 3 show the results.
【0024】[0024]
【表2】 実施例乳液使用群評価項目 塗布試験開始前 3カ月間経過後 肌の潤いが良い 0名 8名 肌にシミがある 10名 2名[Table 2] Evaluation items in the example using the milky lotion After 3 months from the start of the application test, the skin had good moisture 0 8 8 Skin spots 10 2
【0025】[0025]
【表3】 比較例乳液使用群評価項目 塗布試験開始前 3カ月間経過後 肌の潤いが良い 0名 1名 肌にシミがある 10名 9名[Table 3] Comparative example Emulsion use group evaluation item Three months before the start of the application test, good moisture of skin 0 1 1 Stain on skin 10 9
【0026】実施例2 製造実施例3で得られたトウゴマ抽出物を配合した下記
組成の乳液を乳液製造の常法に従い製造した。 トウゴマ抽出物(製造実施例3) 0.05g セトステアリルアルコール 3.5g スクワラン 40g ミツロウ 3g 還元ラノリン 5g エチルパラベン 0.3g POE(20)モノステアリン酸ソルビタン 2g グリセリンモノステアリン酸エステル 2g 1,3−ブチレングリコール 5g 香料 0.03g グリセリン 5g 精製水 残部(全量を100mlとする)Example 2 An emulsion having the following composition containing the castor extract obtained in Production Example 3 was produced according to a conventional method for producing an emulsion. Castor extract (Production Example 3) 0.05 g setosteryl alcohol 3.5 g squalane 40 g beeswax 3 g reduced lanolin 5 g ethyl paraben 0.3 g POE (20) sorbitan monostearate 2 g glycerin monostearate 2 g 1,3-butylene Glycol 5g Fragrance 0.03g Glycerin 5g Purified water Remainder (total amount is 100ml)
【0027】実施例3 製造実施例2で得られたトウゴマ抽出物を配合した下記
組成の化粧水を化粧水製造の常法に従い製造した。 トウゴマ抽出物(製造実施例2) 1g グリセリン 4g 1,3−ブチレングリコール 4g エタノール 7g POE(20)モノオレイン酸ソルビタン0.5g メチルパラベン 0.05g クエン酸 0.01g クエン酸ソーダ 0.1g 香料 0.05g 精製水 残部(全量を100mlとする)Example 3 A lotion containing the castor extract obtained in Production Example 2 and having the following composition was prepared in accordance with a conventional method for preparing a lotion. Castor extract (Production Example 2) 1 g glycerin 4 g 1,3-butylene glycol 4 g ethanol 7 g POE (20) sorbitan monooleate 0.5 g methyl paraben 0.05 g citric acid 0.01 g sodium citrate 0.1 g flavoring 05g purified water remainder (total amount is 100ml)
【0028】実施例4 製造実施例4によるトウゴマ抽出液を配合した下記組成
のパックを常法により製造した。 トウゴマ抽出液(製造実施例4) 10g(固形分として0.013g) ポリビニルアルコール 15g ポリエチレングリコール 3g プロピレングリコール 7g エタノール 10g メチルパラベン 0.05g 香料 0.05g 精製水 残部(全量を100mlとする)Example 4 A pack having the following composition containing the castor extract solution of Production Example 4 was produced by a conventional method. Castor extract (Production Example 4) 10 g (0.013 g as solid content) Polyvinyl alcohol 15 g Polyethylene glycol 3 g Propylene glycol 7 g Ethanol 10 g Methyl paraben 0.05 g Perfume 0.05 g Purified water Remaining (total amount is 100 ml)
【0029】実施例5 製造実施例5で得られたトウゴマ抽出液を配合した下記
組成の乳液を乳液製造の常法に従い製造した。 トウゴマ抽出液(製造実施例5) 10g(固形分として0.05g) セチルアルコール 0.5g ミツロウ 2g POE(20)モノオレイン酸ソルビタン 1g グリセリンモノステアリン酸エステル 1g ヒアルロン酸ナトリウム 0.1g プロピレングリコール 5g エタノール 3g エチルパラベン 0.3g 香料 0.03g 精製水 残部(全量を100mlとする) 実施例2〜5の化粧料は、いずれもシミの改善効果があ
り、使用感にも優れたものであった。Example 5 An emulsion having the following composition containing the castor oil extract obtained in Production Example 5 was produced according to a conventional method for producing an emulsion. Castor extract (Production Example 5) 10 g (0.05 g as solid content) Cetyl alcohol 0.5 g Beeswax 2 g POE (20) sorbitan monooleate 1 g Glycerin monostearate 1 g Sodium hyaluronate 0.1 g Propylene glycol 5 g Ethanol 3 g Ethylparaben 0.3 g Fragrance 0.03 g Purified water Remainder (total amount is 100 ml) The cosmetics of Examples 2 to 5 all had an effect of improving spots and were excellent in usability.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA082 AA111 AA112 AC022 AC072 AC102 AC122 AC302 AC422 AC442 AC482 AD042 AD112 AD332 AD512 CC04 CC05 CC07 DD23 DD31 EE16 4C088 AB46 BA08 BA09 BA10 CA08 MA63 NA14 ZA89 ZC20 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AA082 AA111 AA112 AC022 AC072 AC102 AC122 AC302 AC422 AC442 AC482 AD042 AD112 AD332 AD512 CC04 CC05 CC07 DD23 DD31 EE16 4C088 AB46 BA08 BA09 BA10 CA08 MA63 NA14 ZA89 ZC20
Claims (3)
根部抽出物を有効成分として含有することを特徴とする
メラニン産生抑制剤。1. A melanin production inhibitor comprising, as an active ingredient, a castor root extract having a melanin production inhibitory action.
根部抽出物を有効成分として含有することを特徴とする
美白用化粧料。2. A whitening cosmetic comprising a castor root extract having an inhibitory action on melanin production as an active ingredient.
根部抽出物が水、脂肪族低級アルコール、1,3−ブチ
レングリコールまたはこれらの混合物を抽出溶媒とする
抽出により得られたものである請求項1記載のメラニン
産生抑制剤。3. The castor root extract having a melanin production inhibitory action is obtained by extraction using water, an aliphatic lower alcohol, 1,3-butylene glycol or a mixture thereof as an extraction solvent. Melanin production inhibitor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000057856A JP2001213757A (en) | 2000-01-28 | 2000-01-28 | Melanin production inhibitor and beautifying cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000057856A JP2001213757A (en) | 2000-01-28 | 2000-01-28 | Melanin production inhibitor and beautifying cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001213757A true JP2001213757A (en) | 2001-08-07 |
Family
ID=18578543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000057856A Pending JP2001213757A (en) | 2000-01-28 | 2000-01-28 | Melanin production inhibitor and beautifying cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001213757A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210144725A (en) | 2019-03-29 | 2021-11-30 | 마루젠세이야쿠 가부시키가이샤 | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics |
CN115337231A (en) * | 2021-05-12 | 2022-11-15 | 上海全丽生物科技有限公司 | Fermented product of Luffa cylindrica, its preparation method and topical composition containing the same |
-
2000
- 2000-01-28 JP JP2000057856A patent/JP2001213757A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210144725A (en) | 2019-03-29 | 2021-11-30 | 마루젠세이야쿠 가부시키가이샤 | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics |
CN115337231A (en) * | 2021-05-12 | 2022-11-15 | 上海全丽生物科技有限公司 | Fermented product of Luffa cylindrica, its preparation method and topical composition containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5137457B2 (en) | Stem cell growth factor expression increase inhibitor | |
KR20180004367A (en) | Cosmetic composition with the extract of Aurea Helianthus for skin-whitening | |
KR101885199B1 (en) | Cosmetic composition containing the mixed extract of pomegranate, rosa centifolia flower, carthamus tinctorius and rosa rugosa | |
JP2023171950A (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic | |
KR101817129B1 (en) | Cosmetic Composition Comprising Extracts of Pinecone of Pinus sylvestris | |
KR101007252B1 (en) | a cosmetic composition, a pharmaceutical composition comprising fermented product of extract from labisia pumila | |
US8986758B2 (en) | Method for extracting a traditional herbal medicine component using a polished-rice steaming method | |
KR101854766B1 (en) | Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts | |
KR101775485B1 (en) | Cosmetic composition containing fermentative extract of Spatholobus suberectus Dunn as active ingredient | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20190048935A (en) | Cosmetic composition comprising extract of red onion fermented by aureobasidium pullulans | |
JPH11246424A (en) | Tyrosinase inhibitor and its production | |
JP2001213757A (en) | Melanin production inhibitor and beautifying cosmetic | |
KR20110122448A (en) | Cosmetic composition comprising the extract of filipendula formosa as active ingredient | |
JP2003089630A (en) | Bleaching agent | |
JP5896618B2 (en) | Melanin production inhibitor | |
KR101176525B1 (en) | Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient | |
KR20150034371A (en) | Cosmetic composition comprising the extract of Commelina communis as anti-wrinkle ingredient | |
JP2014172859A (en) | Cosmetic | |
KR20190048931A (en) | Cosmetic composition comprising extract of saliva miltiorrhiza | |
KR20140071716A (en) | Cosmetic composition comprising the extract of Akebia quinata as active ingredi ent | |
KR0180689B1 (en) | Skin whitening composition | |
KR102399220B1 (en) | Manufacturing method of composition for scalp protection and hair growth acceleration | |
JP4886878B2 (en) | Tyrosinase activity inhibitor and whitening cosmetic | |
KR101521579B1 (en) | Skin Whitening and Anti―oxidative Composition Containing Boesenbergia rotunda Extract |